Latest Insider Transactions at Vericel Corp (VCEL)
This section provides a real-time view of insider transactions for Vericel Corp (VCEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vericel Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vericel Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 19
2025
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,938
+3.39%
|
-
|
|
Feb 19
2025
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
853
-1.32%
|
$48,621
$57.78 P/Share
|
|
Feb 19
2025
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+2.64%
|
-
|
|
Feb 18
2025
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,389
-17.78%
|
$250,173
$57.28 P/Share
|
|
Feb 18
2025
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,075
+26.64%
|
-
|
|
Feb 18
2025
|
Jonathan Siegal Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,210
-16.78%
|
$68,970
$57.28 P/Share
|
|
Feb 18
2025
|
Jonathan Siegal Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,920
+26.14%
|
-
|
|
Feb 18
2025
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,259
-5.75%
|
$128,763
$57.28 P/Share
|
|
Feb 18
2025
|
Joseph Anthony Mara Jr Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,379
+15.62%
|
-
|
|
Feb 18
2025
|
Sean C. Flynn Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,463
-30.15%
|
$140,391
$57.28 P/Share
|
|
Feb 18
2025
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,325
+38.87%
|
-
|
|
Feb 18
2025
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,423
-2.16%
|
$309,111
$57.28 P/Share
|
|
Feb 18
2025
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
29,950
+5.77%
|
-
|
|
Feb 18
2025
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
985
-1.54%
|
$56,145
$57.28 P/Share
|
|
Feb 18
2025
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,325
+4.08%
|
-
|
|
Feb 12
2025
|
Kevin F Mclaughlin |
SELL
Open market or private sale
|
Direct |
7,000
-20.64%
|
$385,000
$55.45 P/Share
|
|
Feb 12
2025
|
Kevin F Mclaughlin |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+16.15%
|
$21,000
$3.25 P/Share
|
|
Feb 07
2025
|
Alan L Rubino |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+19.27%
|
$57,000
$3.74 P/Share
|
|
Feb 05
2025
|
Robert L Md Zerbe |
SELL
Open market or private sale
|
Direct |
2,500
-8.59%
|
$155,000
$62.5 P/Share
|
|
Feb 05
2025
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.91%
|
$32,500
$13.05 P/Share
|
|
Feb 05
2025
|
Jonathan Siegal Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,092
-47.52%
|
$66,612
$61.99 P/Share
|
|
Feb 05
2025
|
Jonathan Siegal Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,092
+32.21%
|
$52,416
$48.8 P/Share
|
|
Jan 28
2025
|
Jonathan Siegal Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,908
-76.42%
|
$238,388
$61.99 P/Share
|
|
Jan 28
2025
|
Jonathan Siegal Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,908
+43.32%
|
$187,584
$48.8 P/Share
|
|
Dec 04
2024
|
Paul K Wotton |
SELL
Open market or private sale
|
Direct |
2,600
-8.67%
|
$150,800
$58.72 P/Share
|
|
Dec 02
2024
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-14.63%
|
$580,000
$58.72 P/Share
|
|
Dec 02
2024
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.76%
|
$160,000
$16.66 P/Share
|
|
Nov 22
2024
|
Robert L Md Zerbe |
SELL
Open market or private sale
|
Direct |
2,500
-8.59%
|
$150,000
$60.0 P/Share
|
|
Nov 22
2024
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.91%
|
$32,500
$13.05 P/Share
|
|
Nov 14
2024
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-7.34%
|
$927,500
$53.93 P/Share
|
|
Nov 14
2024
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+6.84%
|
$52,500
$3.02 P/Share
|
|
Nov 13
2024
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-7.34%
|
$962,500
$55.57 P/Share
|
|
Nov 13
2024
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+6.84%
|
$52,500
$3.02 P/Share
|
|
Nov 13
2024
|
Kevin F Mclaughlin |
SELL
Open market or private sale
|
Direct |
7,000
-37.04%
|
$385,000
$55.54 P/Share
|
|
Nov 13
2024
|
Kevin F Mclaughlin |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+27.03%
|
$21,000
$3.74 P/Share
|
|
Nov 12
2024
|
Robert L Md Zerbe |
SELL
Open market or private sale
|
Direct |
2,500
-8.59%
|
$142,500
$57.5 P/Share
|
|
Nov 12
2024
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.91%
|
$32,500
$13.05 P/Share
|
|
Nov 11
2024
|
Robert L Md Zerbe |
SELL
Open market or private sale
|
Direct |
2,500
-8.59%
|
$137,500
$55.0 P/Share
|
|
Nov 11
2024
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.91%
|
$32,500
$13.05 P/Share
|
|
Oct 17
2024
|
Heidi Hagen |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.16%
|
$30,000
$3.74 P/Share
|
|
Oct 17
2024
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-7.34%
|
$700,000
$40.34 P/Share
|
|
Oct 17
2024
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+6.84%
|
$52,500
$3.02 P/Share
|
|
Oct 16
2024
|
Steven C Gilman |
SELL
Open market or private sale
|
Direct |
5,833
-34.65%
|
$239,153
$41.36 P/Share
|
|
Oct 16
2024
|
Steven C Gilman |
BUY
Exercise of conversion of derivative security
|
Direct |
5,833
+25.73%
|
$75,829
$13.05 P/Share
|
|
Oct 16
2024
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-7.34%
|
$717,500
$41.38 P/Share
|
|
Oct 16
2024
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+6.84%
|
$52,500
$3.02 P/Share
|
|
Oct 02
2024
|
Steven C Gilman |
SELL
Open market or private sale
|
Direct |
5,833
-34.65%
|
$233,320
$40.35 P/Share
|
|
Oct 02
2024
|
Steven C Gilman |
BUY
Exercise of conversion of derivative security
|
Direct |
5,833
+25.73%
|
$75,829
$13.05 P/Share
|
|
Oct 01
2024
|
Jonathan Siegal Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
568
-33.57%
|
$23,288
$41.9 P/Share
|
|
Sep 30
2024
|
Jonathan Siegal Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
369
-17.9%
|
$15,498
$42.25 P/Share
|